EMILY RUSSELL
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant WINCHESTER, VA NPI 1699701540
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant VA Novo Nordisk AS All categories
General Payments — all program years on this page
$1,113.60
- Category: General Payments
- Program years: PY2021–2024
- Record count: 20
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $493.39 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.39 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $139.51 | 3 |
| Acerta Pharma LLC | $122.09 | 1 |
| E.R. Squibb & Sons, L.L.C. | $109.41 | 1 |
| Phathom Pharmaceuticals, Inc. | $91.90 | 1 |
| Alkermes, Inc. | $16.23 | 1 |
| Lilly USA, LLC | $14.25 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100284470 | Novo Nordisk Inc | $21.33 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100351438 | Novo Nordisk Inc | $23.77 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100354024 | Novo Nordisk Inc | $94.41 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101796129 | E.R. Squibb & Sons, L.L.C. | $109.41 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105808398 | AstraZeneca Pharmaceuticals LP | $122.09 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120586711 | Alkermes, Inc. | $16.23 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135629673 | Lilly USA, LLC | $14.25 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151202279 | Phathom Pharmaceuticals, Inc. | $91.90 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.